• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生的管理

Management of benign prostatic hyperplasia.

作者信息

Barry M, Roehrborn C

机构信息

General Medicine Division, Massachusetts General Hospital, Boston 02114, USA.

出版信息

Annu Rev Med. 1997;48:177-89. doi: 10.1146/annurev.med.48.1.177.

DOI:10.1146/annurev.med.48.1.177
PMID:9046954
Abstract

Benign prostatic hyperplasia (BPH) is a common cause of morbidity among older men. Primary care physicians need to develop expertise in its management. The causes of BPH are unknown; aging and the presence of male androgens are the dominant risk factors. Obtaining a medical history is a key step in assessing whether lower urinary tract symptoms are due to BPH or to some other process. A reliable and valid seven-item questionnaire has been developed to objectively assess symptom severity. A focused physical examination including a digital rectal exam should be performed, as well as a urinalysis and serum creatinine. Optional tests include uroflowmetry, post-void residual urine, and prostate-specific antigen measurements. BPH is treated primarily to improve the quality, rather than increase the quantity, of life. Optimal decisions about treatment are best made by a clinician and an informed patient working together.

摘要

良性前列腺增生(BPH)是老年男性发病的常见原因。基层医疗医生需要培养其管理方面的专业技能。BPH的病因尚不清楚;衰老以及男性雄激素的存在是主要危险因素。获取病史是评估下尿路症状是由BPH还是其他某种疾病引起的关键步骤。已开发出一种可靠且有效的七项问卷来客观评估症状严重程度。应进行包括直肠指检在内的重点体格检查,以及尿液分析和血清肌酐检测。可选检查包括尿流率测定、排尿后残余尿量测定和前列腺特异性抗原检测。治疗BPH主要是为了提高生活质量,而非延长寿命。关于治疗的最佳决策最好由临床医生和了解情况的患者共同做出。

相似文献

1
Management of benign prostatic hyperplasia.良性前列腺增生的管理
Annu Rev Med. 1997;48:177-89. doi: 10.1146/annurev.med.48.1.177.
2
Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.基于社区的健康老年男性人群中提示良性前列腺增生的下尿路症状的危险因素:克林彭研究
J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.
3
[Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].[良性前列腺增生相关下尿路症状的初始评估、随访及治疗:法国泌尿外科学会下尿路症状委员会指南]
Prog Urol. 2012 Dec;22(16):977-88. doi: 10.1016/j.purol.2012.10.001. Epub 2012 Nov 6.
4
[Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].[功能检查技术在评估良性前列腺增生临床情况中的价值]
Urologe A. 1992 May;31(3):142-9.
5
Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.泌尿科医生和初级保健医生对良性前列腺增生的评估和管理:来自观察性 BPH 登记处的实践模式。
J Urol. 2011 Sep;186(3):971-6. doi: 10.1016/j.juro.2011.04.081. Epub 2011 Jul 24.
6
[Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].[良性前列腺增生(BPH)的流行病学、诊断及治疗的最新趋势与建议]
Aktuelle Urol. 2011 May;42(3):167-78. doi: 10.1055/s-0031-1271453. Epub 2011 May 20.
7
[Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].[压力-流量关系研究在前列腺良性增生评估中的作用]
Prog Urol. 1999 Feb;9(1):151-5.
8
Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.评价一种简易流量计在男性下尿路症状管理中的临床价值。
BJU Int. 2012 Jun;109(11):1690-6. doi: 10.1111/j.1464-410X.2011.10581.x. Epub 2011 Sep 20.
9
Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).钬激光前列腺剜除术(HoLEP)治疗复发性/残留良性前列腺增生(BPH)的可行性。
BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15.
10
Outline of JUA clinical guidelines for benign prostatic hyperplasia.JUA 良性前列腺增生临床指南要点。
Int J Urol. 2011 Nov;18(11):741-56. doi: 10.1111/j.1442-2042.2011.02860.x.

引用本文的文献

1
Claudin-1 down-regulation in the prostate is associated with aging and increased infiltration of inflammatory cells in BPH.前列腺中Claudin-1的下调与衰老以及良性前列腺增生中炎症细胞浸润增加有关。
Am J Clin Exp Urol. 2021 Feb 15;9(1):53-64. eCollection 2021.
2
Photoselective vaporization for the treatment of benign prostatic hyperplasia.用于治疗良性前列腺增生的光选择性汽化术。
Ont Health Technol Assess Ser. 2013 Aug 1;13(2):1-34. eCollection 2013.
3
82-year-old man with bilateral leg swelling.82岁男性,双侧腿部肿胀。
Mayo Clin Proc. 2010 Sep;85(9):859-62. doi: 10.4065/mcp.2009.0654.
4
Patient factors in the implementation of decision aids in general practice: a qualitative study.患者因素在一般实践中决策辅助工具的实施:一项定性研究。
Health Expect. 2010 Mar;13(1):45-54. doi: 10.1111/j.1369-7625.2009.00556.x. Epub 2009 Oct 7.